Background
Traditional Chinese Medicine (TCM) includes both herbal remedies and
non-herbal practices. Chinese cancer patients are at particularly high risk
for herb-drug interactions. Providers, both primary care physicians (PCPs)
and oncologists, frequently do not ask patients about TCM use, with
potentially dangerous consequences.
Objective
This study describes an assessment of TCM use while undergoing
conventional cancer treatment, among a cohort of Chinese immigrant cancer
patients in New York City.
Design and Participants
The Immigrant Health and Cancer Disparities Service at Memorial
Sloan-Kettering Cancer Center (MSKCC) assists underserved cancer patients
through a patient navigation program, the Cancer Portal Project. Six
questions related to TCM are included in the existing Portal Needs
Assessment Intake. Mandarin or Cantonese speaking Portal patients enrolled
between January 2010 and May 2012 were surveyed.
Results
109 Chinese-speaking patients were enrolled in Portal during the
study period. 46 completed the TCM questions. 96% preferred to speak
Mandarin, Cantonese, or Fujianese in the healthcare setting. 39%
(n=18) of the 46 participants reported using TCM since being
diagnosed with cancer. Nearly all (n=16) who used TCM reported using
herbal medicines. Ten TCM users did not describe sharing their use with
Western doctors. Eight (44%) of TCM users reported concurrently
using TCM and conventional cancer treatment.
Conclusions
Larger scale studies should further explore the concurrent use of TCM
and conventional cancer treatment in this unique population. Future research
should also address patient-provider communication related to concurrent use
of TCM and cancer treatment. This is also an important area of education for
both patients and providers.